Trade SGHT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Sight Sciences, Inc. (SGHT) is trading at US$8.35, down 0.36% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$455.03M. Over the past 52 weeks, SGHT has traded between US$3.19 and US$9.24. On Syfe you can trade SGHT with $0 commission and add it to your watchlist.
| Previous close | US$8.38 |
|---|---|
| Market cap | US$455.03M |
| 52-week range | US$3.19 – US$9.24 |
| Volume | 102.47K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sight Sciences, Inc.
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Year: 2021
UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating
Aug 6, 2:47 PM · MT Newswires
Sight Sciences, Inc. (SGHT) stock is trading at US$8.35, -0.36% from the previous close of US$8.38.
The market cap for Sight Sciences, Inc. (SGHT) stock is approximately US$455.03M.
The 52-week high for Sight Sciences, Inc. (SGHT) stock is US$9.24.
The 52-week low for Sight Sciences, Inc. (SGHT) stock is US$3.19.
Sight Sciences, Inc. (SGHT) does not currently pay a dividend.
Stay on top of SGHT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
